KS
Kulkarni Samarth Chairman & CEO
C-suite M
US US · SEC (Form 4)
Browse the complete record of transactions filed by Kulkarni Samarth, Chairman & CEO. Insider active across 1 companies, notably CRISPR Therapeutics AG. In total, 18 disclosures have been logged. The latest transaction was disclosed on 29 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations 18 total
€300,816 25,000 shares @ €12.0326 0.0064% mcap 19.6% of flow
Common Shares
SEC:0001209191-22-040343:0 · 29 Jun 2022
11,834 shares
Common Shares
SEC:0001209191-22-018613:0 · 10 Mar 2022
€28,574 17,750 shares @ €1.6098 4.6% of flow
Common Shares
SEC:0001209191-21-070994 · 20 Dec 2021
€28,574 17,750 shares @ €1.6098 0.0006% mcap 1.9% of flow
Common Shares
SEC:0001209191-21-070994:0 · 20 Dec 2021
80,000 shares
Common Shares
SEC:0001209191-21-068456 · 3 Dec 2021
80,000 shares
Common Shares
SEC:0001209191-21-068456:0 · 3 Dec 2021
€51,634 779 shares @ €66.2825 8.4% of flow
Common Shares
SEC:0001209191-21-068013 · 1 Dec 2021
€51,634 779 shares @ €66.2825 0.0011% mcap 3.4% of flow
Common Shares
SEC:0001209191-21-068013:0 · 1 Dec 2021
€51,529 33,000 shares @ €1.5615 8.4% of flow
Common Shares
SEC:0001209191-21-060775 · 15 Oct 2021
€51,529 33,000 shares @ €1.5615 0.0011% mcap 3.4% of flow
Common Shares
SEC:0001209191-21-060775:0 · 15 Oct 2021
€82,968 787 shares @ €105.4227 13.5% of flow
Common Shares
SEC:0001209191-21-054903 · 1 Sept 2021
€82,968 787 shares @ €105.4227 0.0018% mcap 5.4% of flow
Common Shares
SEC:0001209191-21-054903:0 · 1 Sept 2021
€15,928 1,500 shares @ €10.6189 2.6% of flow
Common Shares
SEC:0001209191-21-050256 · 4 Aug 2021
€15,928 1,500 shares @ €10.6189 0.0003% mcap 1.0% of flow
Common Shares
SEC:0001209191-21-050256:0 · 4 Aug 2021
€310,957 30,000 shares @ €10.3652 50.5% of flow
Common Shares
SEC:0001209191-21-041602 · 15 Jun 2021
€310,957 30,000 shares @ €10.3652 0.0067% mcap 20.3% of flow
Common Shares
SEC:0001209191-21-041602:0 · 15 Jun 2021
€73,834 779 shares @ €94.78 12.0% of flow
Common Shares
SEC:0001209191-21-037801 · 1 Jun 2021
€73,834 779 shares @ €94.78 0.0016% mcap 4.8% of flow
Common Shares
SEC:0001209191-21-037801:0 · 1 Jun 2021
About Kulkarni Samarth Samarth Kulkarni is an executive at CRISPR Therapeutics AG.